Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL587801 | 0.93 | MAPK1 (0.35) | MAPK1TP53GAALMNAALDH1A1 | |
| SCHEMBL588047 | 0.87 | MAPK1 (0.33) | MAPK1TP53 | |
| SCHEMBL12056712 | 0.85 | ABCB1 (0.36) | MAPK1TP53LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL587542 | 0.83 | TP53 (0.32) | TP53GAALMNAALDH1A1ALOX15 | |
| SCHEMBL588649 | 0.83 | POLB (0.32) | LMNA | |
| SCHEMBL587378 | 0.80 | GAA (0.45) | MAPK1TP53GAALMNAALDH1A1 | |
| SCHEMBL587431 | 0.79 | MAPK1 (0.43) | MAPK1TP53GAALMNAALDH1A1 | |
| SCHEMBL587146 | 0.79 | MAPK1 (0.43) | MAPK1TP53GAALMNAALDH1A1 | |
| SCHEMBL587873 | 0.77 | MAPK1 (0.37) | MAPK1TP53GAALMNAALOX15 | |
| SCHEMBL587233 | 0.75 | MAPK1 (0.41) | MAPK1TP53GAALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081925-B1 | Benzoylpyrazoles, their use as herbicides, and intermediates | BAYER CROPSCIENCE AG (DE) | 2012-02-15 | — | — | EP | disclosed |
| EP-2081925-B1 | Benzoylpyrazoles, their use as herbicides, and intermediates | BAYER CROPSCIENCE AG (DE) | 2012-02-15 | — | — | EP | disclosed |
| US-8084398-B2 | Benzoylpyrazoles and herbicide | BAYER CROPSCIENCE AG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084398-B2 | Benzoylpyrazoles and herbicide | BAYER CROPSCIENCE AG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084398-B2 | Benzoylpyrazoles and herbicide | BAYER CROPSCIENCE AG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-20100094023-A1 | BENZOYLPYRAZOLES AND HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-04-15 | — | — | US | disclosed |
| US-20100094023-A1 | BENZOYLPYRAZOLES AND HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-04-15 | — | — | US | disclosed |
| US-20100094023-A1 | BENZOYLPYRAZOLES AND HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-04-15 | — | — | US | disclosed |
| EP-2081925-A1 | BENZOYLPYRAZOLES, THEIR USE AS AS HERBICIDES, AND INTERMEDIATES | Bayer CropScience AG (DE) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008043456-A1 | BENZOYLPYRAZOLES, THEIR USE AS AS HERBICIDES, AND INTERMEDIATES | BAYER CROPSCIENCE AG (DE) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094023-A1 | BENZOYLPYRAZOLES AND HERBICIDE | ATL3, AHR, HACL2 | MAPK1 2176/4885TP53 3125/4885GAA 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.